The surgical drapes and gowns market is projected to register a CAGR of 5.6% during the forecast period (2022-2027).
Almost every aspect of the global economy, including the global supply chain, has been severely disrupted by the Covid-19 pandemic. Worldwide, factories have shut down or slowed production; countries have imposed export and import restrictions, and transportation has slowed or halted. Emerging diseases such as Ebola hemorrhagic fever, hepatitis B, hepatitis C, SARS, and, most recently, the Covid 19 epidemic have raised awareness of the need for personal protective equipment (PPE) worldwide. Since the start of the COVID-19 pandemic, demand for personal protective equipment (PPE) such as surgical masks, gloves, and gowns has skyrocketed.
The growing number of surgical procedures due to sports injuries, accidents, and cardiac surgeries owing to a high prevalence of cardiovascular diseases and other chronic conditions where the surgery is being suggested as mandatory is the primary factor driving the surgical drapes and gowns market.
According to data from Agency for Healthcare Research and Quality (AHRQ), more than 10 million patients undergo surgical procedures as inpatients each year, accounting for over one-fourth of all hospital stays. Cesarean section, orthopedic procedures (hip and knee replacement, hip fracture repair), neurosurgical procedures (spinal fusion and laminectomy), and intraabdominal procedures are the most common inpatient surgical procedures (cholecystectomy and colorectal resections).
Surgical gowns and drapes are also in high demand due to the rising demand for patient and healthcare worker protection and the increasing prevalence of surgical site infections. According to a September 2019 article published by Patient Safety Network (PSNet) on "Surgical Site Infections (SSIs)," SSIs affect 2% to 4% of all patients undergoing inpatient surgical procedures. SSIs are a significant cause of morbidity and mortality after surgery, even though most infections are treatable with antibiotics. They are the most common reason for readmission to the hospital after surgery, and about 3% of patients who contract an SSI will die as a result.
However, infections due to reusable gowns and drapes and product recalls are the major restraints to hamper the growth of the surgical drapes and gowns market.
A surgical Gown is one example of personal protective equipment used in healthcare settings. Different names refer to them according to their intended use in hospitals, such as surgical gowns, isolation gowns, surgical isolation gowns, non-surgical gowns, procedural gowns, operating room gowns, e.t.c.
The COVID-19 pandemic has had a significant impact on the market. As per the December 2020 report titled "Covid-19 - PPE demand & supply perspectives", some industry experts stated that global production of medical PPE increased by at least 300% at its peak as a result of the Covid-19 pandemic, driven primarily by demand for masks. This ramp-up began in late Q1/early Q2 of 2020 to compensate for a global shortage and meet forward-looking surge orders from governments and private entities. Existing international players expanding their production capacities accounted for 50% to 60% of the increase in supply (e.g., DuPont doubled its gowns output).
In the healthcare setting, there is a growing demand for a self-donning surgical gown that healthcare personnel can don without assistance. Also, in the context of crisis management during chronic virus and infectious diseases, using a dress that can be put on and removed quickly and safely to prevent onwards transmission of environmental infection is more important than ever.
North America is Expected to Hold a significant share in the market and is expected to do the Same in the Forecast Period.
The Food and Drug Administration (FDA) released guidance in March 2020 explaining the relaxation of specific regulatory requirements to increase the production and availability of certain personal protective equipment (PPE) such as gowns and gloves as the number of COVID-19 cases rises in the United States and hospitals struggle to keep their doctors and nurses safe.
As a result, PPE manufacturing in the United States has improved since the COVID-19 pandemic began. Various players from different verticals joined the fight as well. Due to COVID-19, Arc'teryx, based in North Vancouver, has shifted some of its production capacity to creating urgently needed surgical gowns for frontline workers in local hospitals.
North America dominates the global surgical drapes and gowns market owing to the presence of well-established market players, a growing number of surgical procedures, and an increasing number of surgical site infections. Surgical site infections (SSIs) are a significant source of health-care-associated infection, according to an UpToDate article from 2022. As per the same source, SSIs are the most frequent nosocomial infection among surgical patients, accounting for 38% of all nosocomial infections. SSIs are thought to develop in 2% to 5% of the more than 30 million individuals who have surgical operations each year (i.e., 1 in 24 patients who undergo inpatient surgery in the United States has a postoperative SSI).
The surgical Drapes and Gowns market is very competitive, with most players competing to increase market shares. Some of the players operating in the market are 3M, Cardinal Health, Medline Industries, Inc., Sterisets International BV, Owens & Minor (Halyard), Surgeine Healthcare, Medica Europe BV, Molnlycke Health Care AB, Primewear, Amaryllis Healthcare Private Limited, Rhysley Limited, Sterimed Group, and Thermo Fisher Scientific Inc.
Intense competition and rapid technological advancements are key factors that confront the market. Key developments in the market include that in June 2019, Ahlstrom-Munksjö launched TrustShield, a versatile portfolio of medical fabrics (Gowns and Drapes) used to protect against surgical lasers, chemicals, and potent chemotherapy drugs.
This product will be delivered within 2 business days.
Almost every aspect of the global economy, including the global supply chain, has been severely disrupted by the Covid-19 pandemic. Worldwide, factories have shut down or slowed production; countries have imposed export and import restrictions, and transportation has slowed or halted. Emerging diseases such as Ebola hemorrhagic fever, hepatitis B, hepatitis C, SARS, and, most recently, the Covid 19 epidemic have raised awareness of the need for personal protective equipment (PPE) worldwide. Since the start of the COVID-19 pandemic, demand for personal protective equipment (PPE) such as surgical masks, gloves, and gowns has skyrocketed.
The growing number of surgical procedures due to sports injuries, accidents, and cardiac surgeries owing to a high prevalence of cardiovascular diseases and other chronic conditions where the surgery is being suggested as mandatory is the primary factor driving the surgical drapes and gowns market.
According to data from Agency for Healthcare Research and Quality (AHRQ), more than 10 million patients undergo surgical procedures as inpatients each year, accounting for over one-fourth of all hospital stays. Cesarean section, orthopedic procedures (hip and knee replacement, hip fracture repair), neurosurgical procedures (spinal fusion and laminectomy), and intraabdominal procedures are the most common inpatient surgical procedures (cholecystectomy and colorectal resections).
Surgical gowns and drapes are also in high demand due to the rising demand for patient and healthcare worker protection and the increasing prevalence of surgical site infections. According to a September 2019 article published by Patient Safety Network (PSNet) on "Surgical Site Infections (SSIs)," SSIs affect 2% to 4% of all patients undergoing inpatient surgical procedures. SSIs are a significant cause of morbidity and mortality after surgery, even though most infections are treatable with antibiotics. They are the most common reason for readmission to the hospital after surgery, and about 3% of patients who contract an SSI will die as a result.
However, infections due to reusable gowns and drapes and product recalls are the major restraints to hamper the growth of the surgical drapes and gowns market.
Key Market Trends
Surgical Gowns segment Holds Significant Share in Surgical Drapes and Gowns Market
A surgical Gown is one example of personal protective equipment used in healthcare settings. Different names refer to them according to their intended use in hospitals, such as surgical gowns, isolation gowns, surgical isolation gowns, non-surgical gowns, procedural gowns, operating room gowns, e.t.c.
The COVID-19 pandemic has had a significant impact on the market. As per the December 2020 report titled "Covid-19 - PPE demand & supply perspectives", some industry experts stated that global production of medical PPE increased by at least 300% at its peak as a result of the Covid-19 pandemic, driven primarily by demand for masks. This ramp-up began in late Q1/early Q2 of 2020 to compensate for a global shortage and meet forward-looking surge orders from governments and private entities. Existing international players expanding their production capacities accounted for 50% to 60% of the increase in supply (e.g., DuPont doubled its gowns output).
In the healthcare setting, there is a growing demand for a self-donning surgical gown that healthcare personnel can don without assistance. Also, in the context of crisis management during chronic virus and infectious diseases, using a dress that can be put on and removed quickly and safely to prevent onwards transmission of environmental infection is more important than ever.
North America dominate the Global Surgical Drapes and Gowns Market
North America is Expected to Hold a significant share in the market and is expected to do the Same in the Forecast Period.
The Food and Drug Administration (FDA) released guidance in March 2020 explaining the relaxation of specific regulatory requirements to increase the production and availability of certain personal protective equipment (PPE) such as gowns and gloves as the number of COVID-19 cases rises in the United States and hospitals struggle to keep their doctors and nurses safe.
As a result, PPE manufacturing in the United States has improved since the COVID-19 pandemic began. Various players from different verticals joined the fight as well. Due to COVID-19, Arc'teryx, based in North Vancouver, has shifted some of its production capacity to creating urgently needed surgical gowns for frontline workers in local hospitals.
North America dominates the global surgical drapes and gowns market owing to the presence of well-established market players, a growing number of surgical procedures, and an increasing number of surgical site infections. Surgical site infections (SSIs) are a significant source of health-care-associated infection, according to an UpToDate article from 2022. As per the same source, SSIs are the most frequent nosocomial infection among surgical patients, accounting for 38% of all nosocomial infections. SSIs are thought to develop in 2% to 5% of the more than 30 million individuals who have surgical operations each year (i.e., 1 in 24 patients who undergo inpatient surgery in the United States has a postoperative SSI).
Competitive Landscape
The surgical Drapes and Gowns market is very competitive, with most players competing to increase market shares. Some of the players operating in the market are 3M, Cardinal Health, Medline Industries, Inc., Sterisets International BV, Owens & Minor (Halyard), Surgeine Healthcare, Medica Europe BV, Molnlycke Health Care AB, Primewear, Amaryllis Healthcare Private Limited, Rhysley Limited, Sterimed Group, and Thermo Fisher Scientific Inc.
Intense competition and rapid technological advancements are key factors that confront the market. Key developments in the market include that in June 2019, Ahlstrom-Munksjö launched TrustShield, a versatile portfolio of medical fabrics (Gowns and Drapes) used to protect against surgical lasers, chemicals, and potent chemotherapy drugs.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M
- Cardinal Health
- Medline Industries, Inc.
- Sterisets International BV
- Owens & Minor (Halyard)
- Surgeine Healthcare
- Medica Europe BV
- Molnlycke Health Care AB
- Amaryllis Healthcare Private Limited
- Rhysley Limited
- Sterimed Group
- Thermo Fisher Scientific Inc.
- Alpha Pro Tech
Methodology
LOADING...
